Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Clasificación en acciones #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Precio por acción
$18.55
Capitalización bursátil
$2.40B
Cambio (1 día)
0.60%
Cambio (1 año)
-
País
US
Comercio Kailera Therapeutics, Inc. (KLRA)

Categoría

Historial de desdoblamientos de acciones de Kailera Therapeutics, Inc. (KLRA)
La acción Kailera Therapeutics, Inc. (símbolo: KLRA) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 27, 2026.
Una acción KLRA comprada antes de Aug 27, 2026 equivaldría hoy a 0 acciones KLRA.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH